Compass Pathways在2026年精神病学大会上于美国启动‘改变难治性抑郁症的旋律’项目，深化医疗专业人士认知

美股速递

Yesterday

在即将召开的2026年精神病学大会（Psych Congress）上，COMPASS Pathways plc（纳斯达克代码：CMPS）正式宣布于美国市场推出全新倡议——“改变难治性抑郁症的旋律”（Change the Tune in TRD）。该项目的核心目标在于拓宽医疗保健专业人士（HCPs）对难治性抑郁症（TRD）的理解边界，推动临床认知的迭代升级。

值得注意的是，这一举措并非简单的宣教活动，而是旨在重塑针对这一复杂精神疾病的诊疗范式。难治性抑郁症长期困扰着大量患者，其对标准疗法的反应不佳，往往导致治疗陷入僵局。COMPASS Pathways此番布局，正是希望通过教育赋能，打破认知壁垒，让一线医疗从业者掌握更前沿、更全面的疾病管理策略。

在2026年精神病学大会这一汇聚全球精神健康领域顶尖专家的平台上，该项目无疑将占据重要位置。通过专题研讨、案例分享及互动式学习模块，‘改变难治性抑郁症的旋律’项目力求将理论认知转化为临床实践中的实际行动，最终改善患者预后。COMPASS Pathways此举，也标志着其在推动精神健康治疗创新道路上迈出了坚实一步，超越了药物研发本身，深入到医疗生态系统的神经中枢。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1111501056"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1111501056\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1111501056?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-09-15 18:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1111501056","market":"us","top_or_hot":-1,"title":"Compass Pathways在2026年精神病学大会上于美国启动‘改变难治性抑郁症的旋律’项目，深化医疗专业人士认知","media":"美股速递","content":"<p>在即将召开的2026年精神病学大会（Psych Congress）上，COMPASS Pathways plc（纳斯达克代码：CMPS）正式宣布于美国市场推出全新倡议——“改变难治性抑郁症的旋律”（Change the Tune in TRD）。该项目的核心目标在于拓宽医疗保健专业人士（HCPs）对难治性抑郁症（TRD）的理解边界，推动临床认知的迭代升级。</p>\n<p>值得注意的是，这一举措并非简单的宣教活动，而是旨在重塑针对这一复杂精神疾病的诊疗范式。难治性抑郁症长期困扰着大量患者，其对标准疗法的反应不佳，往往导致治疗陷入僵局。COMPASS Pathways此番布局，正是希望通过教育赋能，打破认知壁垒，让一线医疗从业者掌握更前沿、更全面的疾病管理策略。</p>\n<p>在2026年精神病学大会这一汇聚全球精神健康领域顶尖专家的平台上，该项目无疑将占据重要位置。通过专题研讨、案例分享及互动式学习模块，‘改变难治性抑郁症的旋律’项目力求将理论认知转化为临床实践中的实际行动，最终改善患者预后。COMPASS Pathways此举，也标志着其在推动精神健康治疗创新道路上迈出了坚实一步，超越了药物研发本身，深入到医疗生态系统的神经中枢。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Compass Pathways在2026年精神病学大会上于美国启动‘改变难治性抑郁症的旋律’项目，深化医疗专业人士认知</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCompass Pathways在2026年精神病学大会上于美国启动‘改变难治性抑郁症的旋律’项目，深化医疗专业人士认知\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1004306016\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">美股速递 </p>\n<p class=\"h-time\">2026-09-15 18:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>在即将召开的2026年精神病学大会（Psych Congress）上，COMPASS Pathways plc（纳斯达克代码：CMPS）正式宣布于美国市场推出全新倡议——“改变难治性抑郁症的旋律”（Change the Tune in TRD）。该项目的核心目标在于拓宽医疗保健专业人士（HCPs）对难治性抑郁症（TRD）的理解边界，推动临床认知的迭代升级。</p>\n<p>值得注意的是，这一举措并非简单的宣教活动，而是旨在重塑针对这一复杂精神疾病的诊疗范式。难治性抑郁症长期困扰着大量患者，其对标准疗法的反应不佳，往往导致治疗陷入僵局。COMPASS Pathways此番布局，正是希望通过教育赋能，打破认知壁垒，让一线医疗从业者掌握更前沿、更全面的疾病管理策略。</p>\n<p>在2026年精神病学大会这一汇聚全球精神健康领域顶尖专家的平台上，该项目无疑将占据重要位置。通过专题研讨、案例分享及互动式学习模块，‘改变难治性抑郁症的旋律’项目力求将理论认知转化为临床实践中的实际行动，最终改善患者预后。COMPASS Pathways此举，也标志着其在推动精神健康治疗创新道路上迈出了坚实一步，超越了药物研发本身，深入到医疗生态系统的神经中枢。</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PSIL","symbol_name":"AdvisorShares Psychedelics ETF","start_time":0,"source_url":"","article_id":"1111501056","we_media_id":"1004306016","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1111501056","pubTimestamp":1789468272,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"美股速递","introduction":"全球快讯第一时间播报","home_visible":1,"id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"在即将召开的2026年精神病学大会上，COMPASS Pathways plc正式宣布于美国市场推出全新倡议——“改变难治性抑郁症的旋律”。该项目的核心目标在于拓宽医疗保健专业人士对难治性抑郁症的理解边界，推动临床认知的迭代升级。在2026年精神病学大会这一汇聚全球精神健康领域顶尖专家的平台上，该项目无疑将占据重要位置。COMPASS Pathways此举，也标志着其在推动精神健康治疗创新道路上迈出了坚实一步，超越了药物研发本身，深入到医疗生态系统的神经中枢。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"PSIL":"AdvisorShares Psychedelics ETF","CMPS":"COMPASS Pathways plc","BK4139":"生物科技"},"translate_title":"Compass Pathways launched the 'Changing the Melody of Refractory Depression' project in the United States at the 2026 Psychiatric Congress, deepening awareness among medical professionals.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PSIL":1,"CMPS":1},"content_text":"在即将召开的2026年精神病学大会（Psych Congress）上，COMPASS Pathways plc（纳斯达克代码：CMPS）正式宣布于美国市场推出全新倡议——“改变难治性抑郁症的旋律”（Change the Tune in TRD）。该项目的核心目标在于拓宽医疗保健专业人士（HCPs）对难治性抑郁症（TRD）的理解边界，推动临床认知的迭代升级。\n值得注意的是，这一举措并非简单的宣教活动，而是旨在重塑针对这一复杂精神疾病的诊疗范式。难治性抑郁症长期困扰着大量患者，其对标准疗法的反应不佳，往往导致治疗陷入僵局。COMPASS Pathways此番布局，正是希望通过教育赋能，打破认知壁垒，让一线医疗从业者掌握更前沿、更全面的疾病管理策略。\n在2026年精神病学大会这一汇聚全球精神健康领域顶尖专家的平台上，该项目无疑将占据重要位置。通过专题研讨、案例分享及互动式学习模块，‘改变难治性抑郁症的旋律’项目力求将理论认知转化为临床实践中的实际行动，最终改善患者预后。COMPASS Pathways此举，也标志着其在推动精神健康治疗创新道路上迈出了坚实一步，超越了药物研发本身，深入到医疗生态系统的神经中枢。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}